Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Assets Average (2022 - 2026)

Zymeworks (ZYME) posted Assets Average of $412.4 million for Q1 2026, up 10.88% sequentially from $371.9 million in Q4 2025, and down 7.19% YoY from $444.3 million in Q1 2025.

Analysis

Zymeworks (ZYME) Assets Average (2022 - 2026) Analysis & Trends

Zymeworks has reported Assets Average for 5 years, with the latest figure at $412.4 million in Q1 2026.

  • Quarterly Assets Average fell 7.19% year-over-year to $412.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $412.4 million (down 7.19% YoY) and the FY2025 annual result came in at $404.8 million, down 22.45% from the prior year.
  • Assets Average advanced to $412.4 million in Q1 2026 per ZYME's latest filing, from $371.9 million in the prior quarter.
  • Over five years, Assets Average peaked at $624.7 million in Q1 2023 and troughed at $371.9 million in Q4 2025.
  • A 5-year average of $498.2 million and a median of $488.3 million in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2023 and 2025: Assets Average climbed 19.84% in 2023, then dropped 22.02% in 2025.
  • Over 5 years, Assets Average stood at $474.5 million in 2022, then gained by 19.84% to $568.6 million in 2023, then retreated by 16.44% to $475.1 million in 2024, then slipped by 21.73% to $371.9 million in 2025, then advanced by 10.88% to $412.4 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $412.4 million, $371.9 million, and $402.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Zymeworks 2.13 Bn 1.86 Bn - 437.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 437.59 Mn
Mar 31, 2026 412.37 Mn
Dec 31, 2025 371.90 Mn
Sep 30, 2025 402.83 Mn
Jun 30, 2025 416.95 Mn
Mar 31, 2025 444.31 Mn
Dec 31, 2024 475.12 Mn
Sep 30, 2024 501.39 Mn
Jun 30, 2024 534.69 Mn
Mar 31, 2024 567.32 Mn
Dec 31, 2023 568.62 Mn
Sep 30, 2023 579.21 Mn
Jun 30, 2023 601.40 Mn
Mar 31, 2023 624.73 Mn
Dec 31, 2022 474.49 Mn